nifedipine has been researched along with Calcinosis in 17 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Calcinosis: Pathologic deposition of calcium salts in tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nifedipine GITS was not effective in slowing down the progression of calcium in advanced atherosclerotic plaques in patients with stable angina pectoris." | 7.74 | Tracking coronary calcification and atherosclerotic lesions in patients with stable angina pectoris undergoing nifedipine therapy. ( de Brouwer, S; Kirwan, BA; Motro, M; Poole-Wilson, PA; Shemesh, J, 2007) |
| "The effects of nifedipine on the survival rate and the cardiovascular calcinosis were investigated in dietary magnesium (Mg)-deficient mice." | 7.68 | Beneficial effects of a calcium antagonist, nifedipine, on death and cardiovascular calcinosis induced by dietary magnesium deficiency in adult mice. ( Ishiguro, S; Nishio, A; Sakaguchi, H; Sakaguchi, R, 1992) |
| "Protective effects of benidipine hydrochloride (KW-3049) against arterial calcinosis and its possible mechanisms of action have been investigated." | 7.68 | Protective effects of benidipine hydrochloride (KW-3049), a calcium antagonist, against experimental arterial calcinosis and endothelial dysfunction in rats. ( Higo, K; Karasawa, A; Kubo, K, 1992) |
| "Ten patients with pulmonary hypertension associated with diffuse systemic sclerosis (1 patient), the CREST syndrome (calcinosis cutis, Reynaud's phenomenon, esophageal dysmotility, sclerodactyl, telangiectasia) (6 patients) and mixed connective tissue disease (3 patients) were studied to assess the effect of oral nifedipine on pulmonary and systemic hemodynamics." | 7.68 | Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease. ( Alpert, MA; Lambert, CR; Mukerji, B; Mukerji, V; Panayiotou, H; Pressly, TA; Sharp, GC, 1991) |
| " The study was designed as a side arm of INSIGHT (International Nifedipine Study: Intervention as Goal for Hypertension Therapy), aimed to show the efficacy of nifedipine once daily versus co-amilozide (hydrochlorothiazide 25 mg, amiloride 2." | 5.09 | Calcium channel blocker nifedipine slows down progression of coronary calcification in hypertensive patients compared with diuretics. ( Motro, M; Shemesh, J, 2001) |
| "6 years, 54% men), a subgroup of 544 participants in the calcification side arm of the INSIGHT (International Nifedipine Study Intervention as Goal for Hypertension Therapy)." | 3.79 | Progression of coronary artery calcification is associated with long-term cardiovascular events in hypertensive adults. ( Apter, S; Grossman, C; Grossman, E; Morag-Koren, N; Motro, M; Shemesh, J, 2013) |
| "Nifedipine GITS was not effective in slowing down the progression of calcium in advanced atherosclerotic plaques in patients with stable angina pectoris." | 3.74 | Tracking coronary calcification and atherosclerotic lesions in patients with stable angina pectoris undergoing nifedipine therapy. ( de Brouwer, S; Kirwan, BA; Motro, M; Poole-Wilson, PA; Shemesh, J, 2007) |
| "The effects of nifedipine on the survival rate and the cardiovascular calcinosis were investigated in dietary magnesium (Mg)-deficient mice." | 3.68 | Beneficial effects of a calcium antagonist, nifedipine, on death and cardiovascular calcinosis induced by dietary magnesium deficiency in adult mice. ( Ishiguro, S; Nishio, A; Sakaguchi, H; Sakaguchi, R, 1992) |
| "Protective effects of benidipine hydrochloride (KW-3049) against arterial calcinosis and its possible mechanisms of action have been investigated." | 3.68 | Protective effects of benidipine hydrochloride (KW-3049), a calcium antagonist, against experimental arterial calcinosis and endothelial dysfunction in rats. ( Higo, K; Karasawa, A; Kubo, K, 1992) |
| "Ten patients with pulmonary hypertension associated with diffuse systemic sclerosis (1 patient), the CREST syndrome (calcinosis cutis, Reynaud's phenomenon, esophageal dysmotility, sclerodactyl, telangiectasia) (6 patients) and mixed connective tissue disease (3 patients) were studied to assess the effect of oral nifedipine on pulmonary and systemic hemodynamics." | 3.68 | Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease. ( Alpert, MA; Lambert, CR; Mukerji, B; Mukerji, V; Panayiotou, H; Pressly, TA; Sharp, GC, 1991) |
| "We examined the progression of coronary atherosclerosis, as measured by dual-section spiral computed tomography, using the total coronary artery calcium score as a quantitative measure of the burden of atherosclerosis." | 2.71 | Accelerated coronary artery calcification in mildly reduced renal function of high-risk hypertensives: a 3-year prospective observation. ( Bursztyn, M; Grossman, E; Motro, M; Shemesh, J, 2003) |
| "Does nifedipine treatment slow down the progression of coronary calcification in diabetic patients? If the answer is yes, is this beneficial effect of nifedipine superior to that of other DHPs with equihypotensive properties? Does nifedipine treatment decrease expression levels of AGEs and RAGE in diabetic atherosclerosis? Is the unique effect of nifedipine on vascular calcification correlated with its AGE or RAGE-suppressing properties? These prospective studies will provide further valuable information whether nifedipine could prevent vascular calcification in diabetic atherosclerosis by blockade the AGE-RAGE signaling in vascular wall cells." | 1.34 | Prevention of diabetic vascular calcification by nifedipine, a dihydropyridine-based calcium channel blocker. ( Matsui, T; Nakamura, K; Yamagishi, S, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (29.41) | 18.7374 |
| 1990's | 5 (29.41) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 1 (5.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shemesh, J | 6 |
| Motro, M | 6 |
| Grossman, C | 1 |
| Morag-Koren, N | 1 |
| Apter, S | 1 |
| Grossman, E | 2 |
| Bursztyn, M | 1 |
| Kirwan, BA | 1 |
| de Brouwer, S | 1 |
| Poole-Wilson, PA | 1 |
| Yamagishi, S | 1 |
| Matsui, T | 1 |
| Nakamura, K | 1 |
| Eisen, A | 1 |
| Tenenbaum, A | 1 |
| Koren-Morag, N | 1 |
| Tanne, D | 1 |
| Golan, A | 1 |
| Fisman, EZ | 1 |
| Schwammenthal, E | 1 |
| Adler, Y | 1 |
| Litovchik, I | 1 |
| Krakover, R | 1 |
| Blatt, A | 1 |
| Vered, Z | 1 |
| Cacciapuoti, F | 1 |
| Perrone, N | 1 |
| Diaspro, R | 1 |
| Galzerano, D | 1 |
| Gentile, S | 1 |
| Lapiello, B | 1 |
| Schäfer, HJ | 1 |
| Riesner, K | 1 |
| Sakaguchi, H | 1 |
| Sakaguchi, R | 1 |
| Ishiguro, S | 1 |
| Nishio, A | 1 |
| Higo, K | 1 |
| Karasawa, A | 1 |
| Kubo, K | 1 |
| Alpert, MA | 2 |
| Pressly, TA | 2 |
| Mukerji, V | 2 |
| Lambert, CR | 1 |
| Mukerji, B | 1 |
| Panayiotou, H | 1 |
| Sharp, GC | 2 |
| Winkler, A | 1 |
| Jackson, RW | 1 |
| Benge, JM | 1 |
| Krog, M | 1 |
| Ejerblad, S | 1 |
| Johansson, H | 1 |
| Wilander, E | 1 |
| Orimo, H | 1 |
| Terashita, K | 1 |
| Nakamura, T | 1 |
| Ohshima, J | 1 |
| Henry, PD | 1 |
1 review available for nifedipine and Calcinosis
| Article | Year |
|---|---|
Atherosclerosis, calcium, and calcium antagonists.
Topics: Animals; Aorta; Arteries; Arteriosclerosis; Calcinosis; Calcium; Calcium Channel Blockers; Cell Surv | 1985 |
4 trials available for nifedipine and Calcinosis
| Article | Year |
|---|---|
Accelerated coronary artery calcification in mildly reduced renal function of high-risk hypertensives: a 3-year prospective observation.
Topics: Aged; Benzothiadiazines; Calcinosis; Calcium Channel Blockers; Coronary Artery Disease; Diuretics; F | 2003 |
Coronary and aortic calcifications inter-relationship in stable angina pectoris: A Coronary Disease Trial Investigating Outcome with Nifedipine GITS (ACTION)--Israeli spiral computed tomography substudy.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Aorta, Thoracic; Aortic Diseases; Calcinosis; Coron | 2007 |
Slowing of mitral valve annular calcium in systemic hypertension by nifedipine and comparisons with enalapril and atenolol.
Topics: Adult; Atenolol; Calcinosis; Echocardiography, Doppler; Enalapril; Female; Heart Valve Diseases; Hum | 1993 |
Calcium channel blocker nifedipine slows down progression of coronary calcification in hypertensive patients compared with diuretics.
Topics: Aged; Amiloride; Calcinosis; Calcium Channel Blockers; Cardiomyopathies; Coronary Artery Disease; Di | 2001 |
12 other studies available for nifedipine and Calcinosis
| Article | Year |
|---|---|
Progression of coronary artery calcification is associated with long-term cardiovascular events in hypertensive adults.
Topics: Adult; Aged; Calcinosis; Cardiovascular Diseases; Coronary Artery Disease; Coronary Vessels; Disease | 2013 |
Tracking coronary calcification and atherosclerotic lesions in patients with stable angina pectoris undergoing nifedipine therapy.
Topics: Aged; Angina Pectoris; Atherosclerosis; Calcinosis; Calcium Channel Blockers; Coronary Vessels; Fema | 2007 |
Prevention of diabetic vascular calcification by nifedipine, a dihydropyridine-based calcium channel blocker.
Topics: Calcinosis; Calcium Channel Blockers; Diabetes Mellitus; Dihydropyridines; Humans; Models, Biologica | 2007 |
Coronary and aortic calcification: is the relationship important?
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Aorta, Thoracic; Aortic Diseases; Calcinosis; Coron | 2007 |
Prevalence of coronary calcification in relation to age, gender and risk factor profile in the insight population.
Topics: Calcinosis; Calcium Channel Blockers; Coronary Angiography; Coronary Disease; Diabetes Complications | 1997 |
[Calcium kinetics of myocardium in experimental hypercalcemia and isoproterenol lesions--ultrastructural and roentgen microanalytical findings].
Topics: Animals; Calcinosis; Calcium; Dihydrotachysterol; Etidronic Acid; Heart; Hypercalcemia; Isoprotereno | 1978 |
Beneficial effects of a calcium antagonist, nifedipine, on death and cardiovascular calcinosis induced by dietary magnesium deficiency in adult mice.
Topics: Animals; Aortic Diseases; Calcinosis; Calcium; Cardiomyopathies; Diet; Magnesium; Magnesium Deficien | 1992 |
Protective effects of benidipine hydrochloride (KW-3049), a calcium antagonist, against experimental arterial calcinosis and endothelial dysfunction in rats.
Topics: Acetylcholine; Animals; Aorta; Arteries; Calcinosis; Calcium; Calcium Channel Blockers; Endothelium, | 1992 |
Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease.
Topics: Adult; Blood Pressure; Calcinosis; Cardiac Catheterization; Cardiac Output; Dyspnea; Esophageal Moti | 1991 |
Value and limitations of calcium channel blockade in the treatment of pulmonary hypertension associated with CREST--case reports.
Topics: Adult; Calcinosis; Diltiazem; Esophageal Diseases; Female; Humans; Hypertension, Pulmonary; Male; Mi | 1988 |
Tissue calcification and alkaline phosphatase activity in uraemic rats.
Topics: Alkaline Phosphatase; Animals; Aortic Diseases; Calcinosis; Calcitriol; Cardiomyopathies; Creatinine | 1988 |
Ca and atherosclerosis.
Topics: Aged; Aging; Animals; Aorta; Arteries; Arteriosclerosis; Bone Diseases; Calcinosis; Calcium; Calcium | 1985 |